Effect of Intravenous Insulin Bolus and Infusion versus Continuous Infusion Alone on Diabetic Ketoacidosis Outcomes in the Emergency Department (INVOKE)
Journal of Acute Care Pharmacotherapy · 01.12.2026 · 2 (4)
DOI: 10.67122/001c.171022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Acute Care Pharmacotherapy, online erschienen am 01.12.2026. Verfasst von Andre Zibner und 3 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose/Background Diabetic Ketoacidosis (DKA) is a serious, acute and life-threatening hyperglycemic emergency characterized by a triad of hyperglycemia, increased serum and/or urine ketone concentrations and metabolic acidosis. In June 2024, the ADA published a consensus report recommending an IV short-acting insulin infusion alone, with the suggestion to administer an initial bolus if a delay in setting up the infusion is expected. INVOKE seeks to add clarification to the current literature surrounding conflicting outcomes of insulin bolus plus infusion or continuous infusion alone in the management of DKA in the emergency department.
Methods
This study was an IRB-approved, single center, retrospective cohort evaluation that was conducted at a large tertiary care hospital with a high-volume emergency department (ED). Patients were included if they were 18 years of age or older, admitted with a diagnosis of DKA per ICD-10 coding and received IV insulin in the ED between October 1, 2024 and December 15, 2025. Patients were excluded if pregnant, received subcutaneous insulin therapy, received multiple IV insulin boluses or were transferred out of the institution within 6 hours of insulin initiation. The primary outcome was a composite safety outcome of interruption of insulin infusion, incidence of hypoglycemia (serum blood glucose < 70 mg/dL) or hypokalemia (serum potassium < 3.4 mEQ/L) within 6 hours of insulin bolus administration or continuous infusion initiation. Secondary outcomes included time to discontinuation of insulin infusion, need for dextrose 50% administration after insulin administration, ICU and hospital length of stay and all-cause mortality.
Results
467 charts were screened and 250 patients were included in this analysis (bolus plus infusion n = 125, continuous infusion only n = 125). Primary outcome occurred in 27.2% of patients who received a bolus and 17.6% of patients who received an infusion only (p = 0.06). There were no significant differences found in the secondary outcomes.
Conclusion
Utilization of an IV insulin bolus plus continuous infusion vs. continuous infusion alone for the management of DKA is not associated with an increase in the composite of hypoglycemia, hypokalemia or interruption of insulin infusion.
Zitieren
APA
Zibner, A., Nguyen, M., Schucker, H., & Oldano, K. (2026). Effect of Intravenous Insulin Bolus and Infusion versus Continuous Infusion Alone on Diabetic Ketoacidosis Outcomes in the Emergency Department (INVOKE). Journal of Acute Care Pharmacotherapy, 2(4). https://doi.org/10.67122/001c.171022
Vancouver
Zibner A, Nguyen M, Schucker H, Oldano K. Effect of Intravenous Insulin Bolus and Infusion versus Continuous Infusion Alone on Diabetic Ketoacidosis Outcomes in the Emergency Department (INVOKE). Journal of Acute Care Pharmacotherapy. 2026;2(4). doi:10.67122/001c.171022
BibTeX
@article{Zibner2026,
author = {Zibner, Andre and Nguyen, Megan and Schucker, Heather and Oldano, Karen},
title = {Effect of Intravenous Insulin Bolus and Infusion versus Continuous Infusion Alone on Diabetic Ketoacidosis Outcomes in the Emergency Department (INVOKE)},
journal = {Journal of Acute Care Pharmacotherapy},
year = {2026},
volume = {2},
number = {4},
doi = {10.67122/001c.171022}
}
EUVIMED